IP Verse

Protease-Regulated Antibody - EP2532676

The patent EP2532676 was granted to Bayer on Mar 22, 2017. The application was originally filed on Aug 16, 2008 under application number EP12172879A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2532676

BAYER
Application Number
EP12172879A
Filing Date
Aug 16, 2008
Status
Opposition Rejected
Nov 22, 2019
Publication Date
Mar 22, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

WHITEDec 21, 2017BOULT WADE TENNANT -

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2007041978
DESCRIPTIONUS4634664
DESCRIPTIONUS4634666
DESCRIPTIONUS4745181
DESCRIPTIONWO9117271
DESCRIPTIONWO9201047
DESCRIPTIONWO9421823
OPPOSITIONWO0191798
OPPOSITIONWO2004009638
OPPOSITIONWO2007024715
OPPOSITIONWO2009021754
OPPOSITIONWO2009025846
SEARCHWO0195942
SEARCHWO2007024715

Non-Patent Literature (NPL) Citations (60) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- AMOUR ET AL., FEBS LETT., (1998), vol. 435, pages 39 - 44
DESCRIPTION- AVARMEAS ET AL., SCAN. J. IMMUNOL., (1978), vol. 8, no. 7, page 7
DESCRIPTION- BAYER ET AL., METH. ENZYMOL., (1979), vol. 62, page 308
DESCRIPTION- BELORGEY ET AL., BIOCHEM. J., (1996), vol. 313, pages 555 - 560
DESCRIPTION- BERGER; KIMMEL, Guide to Molecular Cloning Techniques. Methods in Enzymology, ACADEMIC PRESS, INC., vol. 152
DESCRIPTION- BRENNAN ET AL., FEBS LETT., (1994), vol. 347, pages 80 - 84
DESCRIPTION- BUTENAS ET AL., BIOCHEMISTRY, (2002), vol. 67, pages 3 - 12
DESCRIPTION- CAO ET AL., ADV. DRUG DELIV. REV., (2003), vol. 55, pages 171 - 197
DESCRIPTION- CHANDLER ET AL., J. IMMUNOL. METH., (1982), vol. 53, page 187
DESCRIPTION- CHANG, EUR. J. BIOCHEM., (1985), vol. 151, pages 217 - 224
DESCRIPTION- COUGHLIN, ARTERIOSCLER. THROMB. VASC. BIOL., (1998), vol. 18, pages 514 - 518
DESCRIPTION- DIAN ET AL., LIFE SCIENCES NEWS - AMERSHAM BIOSCIENCES, (2002), vol. 10, pages 1 - 5
DESCRIPTION- EKEKE; ABUKNESHA, J. STEROID BIOCHEM., (1979), vol. 11, page 1579
DESCRIPTION- ENGVALL; PERLMANN, J. IMMUNOL., (1972), vol. 109, page 129
DESCRIPTION- ESMON, CHEST, (2003), vol. 124, pages 26S - 32S
DESCRIPTION- GEOGHEGAN ET AL., IMMUNOL. COMM., (1978), vol. 7, page 1
DESCRIPTION- KILLEEN ET AL., BR. J. CANCER, (2007), vol. 96, pages 262 - 268
DESCRIPTION- KNAPPIK ET AL., J. MOL. BIOL., (2000), vol. 296, pages 57 - 86
DESCRIPTION- KOHRT ET AL., BIOORG. MED. CHEM. LETT., (2005), vol. 15, pages 4752 - 4756
DESCRIPTION- LIGHT ET AL., EUR. J. BIOCHEM., (1999), vol. 262, pages 522 - 533
DESCRIPTION- LIPKIND ET AL., J. BIOL. CHEM., (1995), vol. 270, pages 13277 - 13284
DESCRIPTION- LOFFLER ET AL., LEUKEMIA, (2003), vol. 17, pages 900 - 909
DESCRIPTION- LU ET AL., J. BIOL. CHEM., (2004), vol. 279, pages 2856 - 2565
DESCRIPTION- LU ET AL., J. BIOL. CHEM., (2004), vol. 279, pages 2856 - 2865
DESCRIPTION- LUM ET AL., BLOOD CELLS MOL. DIS., (2004), vol. 32, pages 82 - 87
DESCRIPTION- LUM ET AL., EXP. HEMATOL., (2006), vol. 34, pages 1 - 6
DESCRIPTION- MERRIFIELD, J. AM. CHEM. SOC., (1963), vol. 85, pages 2149 - 2154
DESCRIPTION- MIAO ET AL., J. BIOL. CHEM., (1992), vol. 267, pages 7395 - 7401
DESCRIPTION- MINOD ET AL., J. BIOL. CHEM., (2006), vol. 281, pages 38302 - 38313
DESCRIPTION- MOORE ET AL., ARCH. PHYSIOL. BIOCHEM., (2002), vol. 110, pages 16 - 25
DESCRIPTION- NAGAI ET AL., METHODS ENZYMOL., (1987), vol. 153, pages 461 - 481
DESCRIPTION- OESTBERG ET AL., HYBRIDOMA, (1983), vol. 2, pages 361 - 367
DESCRIPTION- PHILLIPS ET AL., J. MED. CHEM., (1998), vol. 41, pages 3557 - 3562
DESCRIPTION- RIESTER ET AL., PROC. NATL. ACAD. SCI. USA, (2005), vol. 102, pages 8597 - 8602
DESCRIPTION- ROBERGE ET AL., SCIENCE, (1995), vol. 269, pages 202 - 204
DESCRIPTION- SAENKO ET AL., HAEMOPHILIA, (2006), vol. 12, pages 42 - 51
DESCRIPTION- SAMBROOK ET AL., Molecular Cloning: A Laboratory Manual(Second Edition,, COLD SPRING HARBOR LABORATORY PRESS, (1989), vol. 1-3
DESCRIPTION- SCAMUFFA ET AL., FASEB J., (2006), vol. 20, pages 1954 - 1963
DESCRIPTION- SEGAL ET AL., CURR. OPIN. IMMUNOL., (1999), vol. 11, pages 558 - 562
DESCRIPTION- SJOLANDER; URBANICZKY, ANAL. CHEM., (1991), vol. 63, pages 2338 - 2345
DESCRIPTION- SZABO ET AL., CURR. OPIN. STRUCT. BIOL., (1995), vol. 5, pages 699 - 705
DESCRIPTION- TALAC ET AL., J. BIOL. REGUL. HOMEOST. AGENTS, (2000), vol. 14, pages 175 - 181
DESCRIPTION- TOMLINSON ET AL., METHODS ENZYMOL., (2000), vol. 326, pages 461 - 479
DESCRIPTION- TRAIL ET AL., CANCER IMMUNOL. IMMUNOTHER., (2003), vol. 52, pages 328 - 337
DESCRIPTION- VEVERIS-LOWE ET AL., SEMIN. THROMB. HEMOST., (2007), vol. 33, pages 87 - 99
DESCRIPTION- WEEKS ET AL., CLIN. CHEM., (1983), vol. 29, no. 8, pages 1474 - 1479
DESCRIPTION- WOLF ET AL., DRUG DISCOV. TODAY, (2005), vol. 10, pages 1237 - 1244
DESCRIPTION- WONG ET AL., CLIN. IMMUNOL. IMMUNOPATHOL., (1991), vol. 58, pages 236 - 250
DESCRIPTION- WONG ET AL., J. IMMUNOL., (1987), vol. 139, pages 1369 - 1374
DESCRIPTION- WU ET AL., NAT BIOTECHNOL., (2007), vol. 25, pages 1290 - 1297
DESCRIPTION- XUAN ET AL., CANCER RES., (2006), vol. 66, pages 3611 - 3619
DESCRIPTION- YAN ET AL., PROC. NATL. ACAD. SCI. USA, (2000), vol. 97, pages 8525 - 8529
OPPOSITION- WU et al., "Molecular construction and optimization of July/August 2009 anti-human II-1alpha/beta dual variable domain immunoglobulin ( DVD -Ig) molecules", mAbs, (20090000), vol. 1, no. 4, pages 339 - 347, XP002657321
OPPOSITION- METZ et al., "Bispecific antibody derivatives with restricted 13 September 2012 binding functionalities that are activated by proteolytic processing", Protein Engineering, Design & Selection, (20121001), vol. 25, no. 10, pages 571 - 580, XP055069821
OPPOSITION- DIGIAMMARINO et al., "Ligand association rates to the inner- October 2011 variable-domain of a dual-variable-domain immunoglobulin are significantly impacted by linker design", mAbs, (20110900), vol. 3, no. 5, pages 487 - 494, XP009168882
SEARCH- DENNY ET AL, "Prodrug strategies in cancer therapy", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, vol. 36, no. 7-8, ISSN 0223-5234, (20010801), pages 577 - 595, (20010801), XP027556826 [A] 1-13 * the whole document *
SEARCH- ORAN ERSTER ET AL, "Site-specific targeting of antibody activitymediated by disease-associated proteases", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 161, no. 3, doi:10.1016/J.JCONREL.2012.05.035, ISSN 0168-3659, (20120517), pages 804 - 812, (20120523), XP028409044 [T] 1-13 * the whole document * * in particular figure 1 *
SEARCH- LITTLE M ET AL, "Of mice and men: hybridoma and recombinant antibodies", IMMUNOLOGY TODAY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, (20000801), vol. 21, no. 8, ISSN 0167-5699, pages 364 - 370, XP004215163 [A] 4 * page 367, column LEFT; figure 3 *
SEARCH- WÜEST THOMAS ET AL, "TNF-Selectokine: a novel prodrug generated for tumor targeting and site-specific activation of tumor necrosis factor", ONCOGENE, NATURE PUBLISHING GROUP, GB, (20020620), vol. 21, no. 27, doi:10.1038/SJ.ONC.1205193, ISSN 0950-9232, pages 4257 - 4265, XP002461744 [A] 1-13 * the whole document *
SEARCH- DONALDSON JOSHUA M ET AL, "Design and development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodies", CANCER BIOLOGY AND THERAPY, LANDES BIOSCIENCE, US, (20091101), vol. 8, no. 22, ISSN 1538-4047, pages 2147 - 2152, XP009135774 [T] 1-13 * the whole document * * in particular figure 1 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents